Earnings Outlook: Here’s how the ‘pause’ on J&J’s COVID-19 shot may or may not affect the company’s earnings
To what degree will Johnson & Johnson’s COVID-19 vaccine manufacturing issues and the federal ‘pause’ over safety concerns weigh on investors’ mind when the company reports earnings next week?
